South Shore Hospital’s William Tollefsen, MD, was recently presented with the Mark E. Weinstein Award at the Metropolitan Boston Emergency Medical Services Council (MBEMSC) annual awards dinner on Thursday, November 8. The award is presented annually to an individual who demonstrates outstanding...

Since this post was published, changes have been made to COVID-19 testing at South Shore Health. For the latest testing information, please visit our COVID-19 page. South Shore Health’s COVID-19 drive-thru testing site has been relocated to South Shore Medical Center at 143 Longwater Drive in...

January is National Blood Donor Month, an ideal time to spotlight the life-saving efforts of South Shore Health’s Blood Bank, which ensures safe transfusions through blood typing and cross-matching, stores and manages our blood inventory, and provides essential support during emergency situations.

Longtime South Shore Health supporters Rosemary and Jim Phalen will be named “Home Care Champions” and receive a unique Luminaria medallion alongside Christopher Oddleifson, Chief Executive Officer of Rockland Trust Company at this year's 9th annual Luminaria event.

After an unannounced and extensive site visit, Massachusetts Department of Public Health (DPH) surveyors certified the South Shore VNA as being in compliance with all regulatory requirements and without any deficiencies, meaning in essence they earned a perfect review.

Duxbury’s Rosemary and Jim Phalen; Christopher Oddleifson, Chief Executive Officer of Rockland Trust Company named “Home Care Champions."

South Shore Health is the only organization in southeastern Massachusetts recognized to perform the specialized ultrasound.

South Shore Health is among five healthcare organizations which has been granted funding to expand access to postpartum and newborn care across Massachusetts. The state’s Health Policy Commission recently approved $1.4m in awards to five applicants for the Cost-Effective, Coordinated Care for...

With the region experiencing yet another surge in cases of COVID-19, the Mobile Integrated Health (MIH) program is participating in an innovative clinical trial that brings a much talked about drug to treat COVID-19 (remdesivir) to patients at home, instead of at the hospital.